NM_032806.6:c.569G>A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_032806.6(POMGNT2):c.569G>A(p.Arg190Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R190W) has been classified as Uncertain significance.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- myopathy caused by variation in POMGNT2Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POMGNT2 | NM_032806.6 | c.569G>A | p.Arg190Gln | missense_variant | Exon 2 of 2 | ENST00000344697.3 | NP_116195.2 | |
| POMGNT2 | NM_001437285.1 | c.569G>A | p.Arg190Gln | missense_variant | Exon 3 of 3 | NP_001424214.1 | ||
| POMGNT2 | XM_011534163.3 | c.569G>A | p.Arg190Gln | missense_variant | Exon 3 of 3 | XP_011532465.1 | ||
| POMGNT2 | XM_017007353.2 | c.569G>A | p.Arg190Gln | missense_variant | Exon 4 of 4 | XP_016862842.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POMGNT2 | ENST00000344697.3 | c.569G>A | p.Arg190Gln | missense_variant | Exon 2 of 2 | 1 | NM_032806.6 | ENSP00000344125.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152166Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000876 AC: 22AN: 251028 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461788Hom.: 0 Cov.: 37 AF XY: 0.0000344 AC XY: 25AN XY: 727198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74454 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 190 of the POMGNT2 protein (p.Arg190Gln). This variant is present in population databases (rs200080447, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with POMGNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 540490). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at